Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

SELL
$62.32 - $89.47 $1.36 Million - $1.95 Million
-21,764 Reduced 46.2%
25,340 $2.18 Million
Q3 2022

Nov 10, 2022

SELL
$59.54 - $68.01 $29,174 - $33,324
-490 Reduced 1.03%
47,104 $2.91 Million
Q2 2022

Aug 10, 2022

SELL
$57.72 - $65.01 $2.02 Million - $2.27 Million
-34,961 Reduced 42.35%
47,594 $2.94 Million
Q1 2022

May 10, 2022

BUY
$57.92 - $72.58 $11,584 - $14,516
200 Added 0.24%
82,555 $4.91 Million
Q4 2021

Feb 09, 2022

BUY
$64.88 - $73.64 $1.81 Million - $2.05 Million
27,826 Added 51.03%
82,355 $5.98 Million
Q3 2021

Nov 05, 2021

SELL
$67.69 - $73.03 $15,907 - $17,162
-235 Reduced 0.43%
54,529 $3.81 Million
Q2 2021

Aug 05, 2021

BUY
$63.47 - $69.35 $65,691 - $71,777
1,035 Added 1.93%
54,764 $3.77 Million
Q1 2021

May 12, 2021

BUY
$60.0 - $68.46 $69,240 - $79,002
1,154 Added 2.19%
53,729 $3.47 Million
Q4 2020

Feb 08, 2021

BUY
$56.65 - $64.55 $1.22 Million - $1.39 Million
21,537 Added 69.39%
52,575 $3.06 Million
Q3 2020

Nov 10, 2020

BUY
$62.1 - $78.08 $146,990 - $184,815
2,367 Added 8.26%
31,038 $1.96 Million
Q2 2020

Aug 12, 2020

SELL
$72.34 - $84.0 $2.08 Million - $2.41 Million
-28,741 Reduced 50.06%
28,671 $2.21 Million
Q1 2020

May 07, 2020

SELL
$62.63 - $80.22 $5.16 Million - $6.61 Million
-82,340 Reduced 58.92%
57,412 $4.29 Million
Q4 2019

Feb 06, 2020

BUY
$61.62 - $67.78 $154,974 - $170,466
2,515 Added 1.83%
139,752 $9.08 Million
Q3 2019

Nov 08, 2019

BUY
$62.51 - $69.0 $272,481 - $300,771
4,359 Added 3.28%
137,237 $8.7 Million
Q2 2019

Aug 12, 2019

BUY
$61.87 - $69.38 $49,434 - $55,434
799 Added 0.6%
132,878 $8.98 Million
Q1 2019

May 08, 2019

BUY
$62.53 - $70.05 $500 - $560
8 Added 0.01%
132,079 $8.59 Million
Q4 2018

Jan 31, 2019

SELL
$60.54 - $79.0 $436,311 - $569,353
-7,207 Reduced 5.17%
132,071 $8.26 Million
Q3 2018

Nov 07, 2018

SELL
$71.28 - $78.92 $29,581 - $32,751
-415 Reduced 0.3%
139,278 $10.8 Million
Q2 2018

Aug 09, 2018

BUY
$64.88 - $75.68 $1.67 Million - $1.95 Million
25,783 Added 22.63%
139,693 $9.9 Million
Q1 2018

May 11, 2018

SELL
$72.84 - $88.8 $231,631 - $282,384
-3,180 Reduced 2.72%
113,910 $8.59 Million
Q4 2017

Feb 09, 2018

BUY
$71.15 - $83.52 $56,493 - $66,314
794 Added 0.68%
117,090 $8.39 Million
Q3 2017

Nov 03, 2017

BUY
$72.11 - $85.47 $8.39 Million - $9.94 Million
116,296
116,296 $9.42 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Rock Point Advisors, LLC Portfolio

Follow Rock Point Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Point Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rock Point Advisors, LLC with notifications on news.